PAVmed Inc. (PAVM)

Market Cap	10.22M
Revenue (ttm)	1.99M
Net Income (ttm)	72.45M
Shares Out	17.62M
EPS (ttm)	0.96
PE Ratio	0.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,364
Open	0.5900
Previous Close	0.5875
Day's Range	0.5725 - 0.5900
52-Week Range	0.5420 - 1.9000
Beta	1.06
Analysts	Strong Buy
Price Target	19.00 (+3,175.86%)
Earnings Date	Aug 11, 2025

About PAVM

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company’s lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, incl...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 28, 2016
• Employees: 39
• Stock Exchange: NASDAQ
• Ticker Symbol: PAVM
• Website: https://www.pavmed.com

Analyst Summary

According to one analyst, the rating for PAVM stock is "Strong Buy" and the 12-month stock price target is $19.0.

Price Target

$19.0

(3,175.86% upside)

Analyst Consensus: Strong Buy